missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human B3GAT1 (aa 32-86) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (95%), Rat (95%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-84813 (PA5-84813. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The protein encoded by this gene is a member of the glucuronyltransferase gene family. These enzymes exhibit strict acceptor specificity, recognizing nonreducing terminal sugars and their anomeric linkages. This gene product functions as the key enzyme in a glucuronyl transfer reaction during the biosynthesis of the carbohydrate epitope HNK-1 (human natural killer-1, also known as CD57 and LEU7). Alternate transcriptional splice variants have been characterized.
Specifications
Specifications
| Accession Number | Q9P2W7 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 27087 |
| Name | Human B3GAT1 (aa 32-86) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 0710007K08Rik; AI846286; B3GAT1; Beta-1,3-glucuronyltransferase 1; beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P); CD57; Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1; GLCATP; glcAT-P; GLCUATP; GlcUAT-P; Glucuronosyltransferase P; glucuronosyltransferase-P; Hnk1; Hnk-1; LEU7; LEU7 antigen; NK1; NK-1; UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase |
| Common Name | B3GAT1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction